Skip to main content
. 2021 Feb 25;36(1):693–706. doi: 10.1080/14756366.2021.1890726

Figure 4.

Figure 4.

4-Aryl/hetroaryl-2-aminopyridines/pyrimidines CDK9 inhibitors published by Novartis.